Free Trial

CVS Health (CVS) Earnings Date, Estimates & Call Transcripts

CVS Health logo
$67.22 -1.42 (-2.07%)
Closing price 03/21/2025 03:59 PM Eastern
Extended Trading
$67.35 +0.13 (+0.19%)
As of 03/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 29Before Market OpensEstimated
Actual EPS
(Feb. 12)
$1.19 Beat By $0.30
Consensus EPS
(Feb. 12)
$0.89

CVS Health announced Q4 2024 earnings on February 12, 2025, reporting an EPS of $1.19, which beat analysts' consensus estimates of $0.89 by $0.30. With a trailing EPS of $3.66 and a P/E Ratio of 18.37, CVS Health's earnings are expected to grow 14.94% next year, from $5.89 to $6.77 per share.

CVS Upcoming Earnings

CVS Health's next earnings date is estimated for Tuesday, April 29, 2025, based off prior year's reporting schedules.

Get CVS Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CVS Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

CVS Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$1.62$2.26$1.94 
Q2 20252$1.61$2.20$1.91 
Q3 20251$1.28$1.28$1.28 
Q4 20251$1.37$1.37$1.37 
FY 20256$5.88$7.11 $6.50
Remove Ads

CVS Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/29/2025
(Estimated)
-------
2/12/2025Q4 2024$0.89$1.19+$0.30$1.30$96.90B-
11/6/2024Q3 2024$1.0750$1.09+$0.0150$2.11$92.72B$95.43B
8/7/2024Q2 2024$1.73$1.83+$0.10$2.25$91.41B$91.23B
5/1/2024Q1 2024$1.69$1.31 -$0.38$1.74$89.33B$88.44B
2/7/2024Q4 2023$2.01$2.12+$0.11$2.66$90.58B$93.81B
11/1/2023Q3 2023$2.13$2.21+$0.08$2.67$88.29B$89.76B
8/2/2023Q2 2023$2.12$2.21+$0.09$2.94$86.41B$88.92B
5/3/2023Q1 2023$2.07$2.20+$0.13$2.75$80.67B$85.28B

CVS Health Earnings - Frequently Asked Questions

CVS Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based off last year's report dates. Learn more on CVS's earnings history.

CVS Health issued an update on its FY 2025 earnings guidance on Wednesday, February, 12th. The company provided earnings per share guidance of 5.750-6.000 for the period, compared to the consensus earnings per share estimate of 5.970. The company issued revenue guidance of -.

In the previous quarter, CVS Health (NYSE:CVS) reported $1.19 earnings per share (EPS) to beat the analysts' consensus estimate of $0.89 by $0.30. Learn more on analysts' earnings estimate vs. CVS's actual earnings.

The conference call for CVS Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for CVS Health's latest earnings report can be read online.
Read Transcript

CVS Health's earnings report can be found in their filing with the SEC.
View SEC filing

CVS Health (NYSE:CVS) has a recorded annual revenue of $372.81 billion.

CVS Health (NYSE:CVS) has a recorded net income of $4.61 billion. CVS has generated $3.66 earnings per share over the last four quarters.

CVS Health (NYSE:CVS) has a trailing price-to-earnings ratio of 18.37 and a forward price-to-earnings ratio of 11.41. The price/earnings-to-growth ratio is 0.98.

CVS Health's earnings are expected to grow from $5.89 per share to $6.77 per share in the next year, which is a 14.94% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NYSE:CVS) was last updated on 3/23/2025 by MarketBeat.com Staff
From Our Partners